Valuation: Edwards Lifesciences Corporation

Market Cap 52.8B 45.6B 42.85B 38.97B 73.27B 5,049B 74.48B 502B 196B 2,528B 198B 194B 8,402B P/E 2026 *
36.2x
P/E 2027 * 27.7x
Enterprise Value 49.17B 42.47B 39.9B 36.29B 68.23B 4,701B 69.36B 468B 183B 2,354B 185B 181B 7,824B EV / Sales 2026 *
7.27x
EV / Sales 2027 * 6.41x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.04%
1 week+2.10%
Current month+6.43%
1 month+1.68%
3 months+12.61%
6 months+20.73%
Current year+7.45%
1 week 88.6
Extreme 88.605
93.91
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
8/11/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+2.10%+17.17%+13.75% 52.8B
-1.28%-0.96%+21.29%+8.87% 218B
-0.71%-1.13%-3.70%-21.28% 142B
-1.68%+4.14%-17.31%+29.31% 139B
+0.27%+5.11%-50.24%+0.97% 75.11B
+0.69%-0.51%-15.97%-16.56% 50.66B
-0.51%+1.75%+24.95%+17.28% 41.95B
-0.32%+1.31%+40.42%+42.93% 40.49B
-0.14%+2.68%+0.04%+2.63% 33.28B
-1.01%+5.91%-21.16%+24.11% 32.38B
Average -0.19%+2.19%-0.45%+10.20% 82.59B
Weighted average by Cap. -0.18%+1.41%+0.02%+7.60%

Financials

2026 *2027 *
Net sales 6.76B 5.84B 5.49B 4.99B 9.38B 646B 9.53B 64.28B 25.13B 324B 25.38B 24.83B 1,076B 7.43B 6.42B 6.03B 5.48B 10.31B 710B 10.48B 70.65B 27.62B 356B 27.89B 27.29B 1,182B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2.02B 13.65B 5.34B 68.72B 5.39B 5.27B 228B 1.9B 1.64B 1.54B 1.4B 2.63B 181B 2.68B 18.04B 7.05B 90.82B 7.12B 6.97B 302B
Net Debt -3.63B -3.14B -2.95B -2.68B -5.04B -347B -5.12B -34.53B -13.5B -174B -13.63B -13.34B -578B -5.19B -4.49B -4.22B -3.83B -7.21B -497B -7.33B -49.4B -19.31B -249B -19.5B -19.08B -827B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-14 $91.60 -1.04% 2,856,892
26-08-13 $92.56 -0.53% 2,809,926
26-08-12 $93.05 -0.65% 2,340,306
26-08-11 $93.66 +1.77% 3,138,661
26-08-10 $92.03 +2.57% 4,443,994
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.60USD
Average target price
100.96USD
Spread / Average Target
+10.22%

Quarterly revenue - Rate of surprise